GSK plc GSK
NYSE GSK
$46.50 -0.02 (-0.04%)
At close: Oct 9, 2026 · 4:00 PM EDT

Gsk (GSK) Common Equity (2009 - 2026)

Updated

Gsk (GSK) recorded Common Equity of $23.05 billion in the quarter ended Jun 30, 2026, up 20.4% from $19.15 billion a year earlier but down 1.9% from the prior quarter.

Analysis

Gsk (GSK) Common Equity (2009 - 2026) Analysis & Trends

As of Dec 31, 2025, Gsk reported Common Equity of $21.04 billion, up 25.8% from the prior year.

  • Annual Common Equity has increased for three straight years, though with a five-year compound annual growth rate of -4.7% (years ended Dec 2020 to Dec 2025).
  • Across earlier years, Common Equity came in at $16.73 billion in the year ended Dec 31, 2024 (+5.1%), $15.91 billion in the year ended Dec 31, 2023 (+27.4%), $12.49 billion in the year ended Dec 31, 2022 (-57.4%) and $29.36 billion in the year ended Dec 31, 2021 (+9.9%).
  • Quarterly Common Equity has ranged from $10.27 billion in the quarter ended Sep 30, 2022 to $36.03 billion in the quarter ended Mar 31, 2022 over the past five years.
  • On a year-over-year basis, Common Equity has increased for 12 consecutive quarters, with growth averaging 16.6% over the last eight quarters.
  • Peak year-over-year performance for Common Equity in the last five years was growth of 55.6% in the quarter ended Sep 30, 2023, against a decline of 65.7% in the quarter ended Sep 30, 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $23.49 billion (quarter ended Mar 31, 2026), $21.22 billion (quarter ended Dec 31, 2025) and $21.26 billion (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Eli Lilly 1,109.58 Bn 1,078.16 Bn 19.71 Bn 33.88 Bn
2 Johnson & Johnson 630.16 Bn 548.69 Bn 17.26 Bn 84.97 Bn
3 AbbVie 488.57 Bn 461.73 Bn 12.70 Bn -5.94 Bn
4 Merck 359.15 Bn 313.58 Bn 12.21 Bn 41.98 Bn
5 Novartis Ag 274.32 Bn 238.71 Bn 11.24 Bn 41.95 Bn
6 Astrazeneca 246.73 Bn 220.50 Bn 12.86 Bn 50.37 Bn
7 Amgen 224.28 Bn 179.68 Bn 7.24 Bn 11.69 Bn
8 Gilead Sciences 187.60 Bn 161.71 Bn 6.22 Bn 11.83 Bn
9 Pfizer 161.13 Bn 108.08 Bn 10.94 Bn 85.49 Bn
10 Gsk 100.33 Bn 81.91 Bn 8.24 Bn 23.05 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 23.05 Bn
Mar 31, 2026 23.49 Bn
Dec 31, 2025 21.22 Bn
Sep 30, 2025 21.26 Bn
Jun 30, 2025 19.15 Bn
Mar 31, 2025 17.20 Bn
Dec 31, 2024 16.80 Bn
Sep 30, 2024 17.48 Bn
Jun 30, 2024 17.38 Bn
Mar 31, 2024 16.78 Bn
Dec 31, 2023 15.88 Bn
Sep 30, 2023 15.98 Bn
Jun 30, 2023 15.22 Bn
Mar 31, 2023 13.75 Bn
Dec 31, 2022 11.84 Bn
Sep 30, 2022 10.27 Bn
Jun 30, 2022 28.51 Bn
Mar 31, 2022 36.03 Bn
Dec 31, 2021 28.77 Bn
Sep 30, 2021 29.98 Bn
API Access

Gsk Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=GSK&period=max&api_key=YOUR_API_KEY